FDA label
What is Klayesta used for?
Klayesta contains nystatin. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “KLAYESTA is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicans and other susceptible Candida species.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Klayesta?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Klayesta, powder
Indications and Usage, quoted from the label by Epic Pharma, LLC (ANDA210532). Cross-references to other label sections are left out.
KLAYESTA is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicans and other susceptible Candida species.
KLAYESTA is not indicated for systemic, oral, intravaginal or ophthalmic use.
Source: DailyMed label, set id 0df13b1e-0e07-4123-a83a-1d7afb56170f, version 3, effective December 17, 2025. NDC 42806-186, one of 1 listing for this product.
Questions
What is Klayesta used for?
The FDA label says: “KLAYESTA is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicans and other susceptible Candida species.”
What drug class is Klayesta?
FDA lists nystatin in the Polyene Antifungal established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.